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A ROLE FOR SETMAR IN GENE REGULATION: INSIGHTS FROM STRUCTURAL ANALYSIS 
OF THE DNA-BINDING DOMAIN IN COMPLEX WITH DNA 
 
SETMAR is a chimeric protein that originates from the fusion of a SET domain to the 
mariner Hsmar1 transposase. This fusion event occurred approximately 50 million years 
ago, after the split of an anthropoid primate ancestor from the prosimians. Thus, 
SETMAR is only expressed in anthropoid primates, such as humans, apes, and New 
World monkeys. Evolutionary sequence analyses have revealed that the DNA-binding 
domain, one of the two functional domains in the Hsmar1 transposase, has been 
subjected to a strong purifying selection. Consistent with these analyses, SETMAR 
retains robust binding specificity to its ancestral terminal inverted repeat (TIR) DNA. In 
the human genome, this TIR sequence is dispersed in over 1500 perfect or nearly perfect 
sites. Given that many DNA-binding domains of transcriptional regulators are derived 
from transposases, we hypothesized that SETMAR may play a role in gene regulation. In 
this thesis, we determined the crystal structures of the DNA-binding domain bound to 
both its ancestral TIR DNA and a variant TIR DNA sequence at 2.37 and 3.07 Å, 
respectively. Overall, the DNA-binding domain contains two helix-turn-helix (HTH) motifs 
linked by two AT-hook motifs and dimerizes through its HTH1 motif. In both complexes, 
minor groove interactions with the AT-hook motifs are similar, and major groove 
vii 
interactions with HTH1 involve a single residue. However, four residues from HTH2 
participate in nucleobase-specific interactions with the TIR and only two with the variant 
DNA sequence. Despite these differences in nucleobase-specific interactions, the 
DNA-binding affinities of SETMAR to TIR or variant TIR differ by less than two-fold. From 
cell-based studies, we found that SETMAR represses firefly luciferase gene expression 
while the DNA-binding deficient mutant does not. A chromatin immunoprecipitation 
assay further confirms that SETMAR binds the TIR sequence in cells. Collectively, our 
studies suggest that SETMAR functions in gene regulation. 
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INTRODUCTION 
A. Human DNA transposons 
Transposons, also called “jumping genes” or transposable elements, are mobile DNA 
sequences that are able to move themselves within the host genome (Wicker et al. 
2007). Based on their transposition mechanisms, transposons can be classified into two 
classes: retrotransposons and DNA transposons. Unlike retrotransposons, which move 
via an RNA intermediate using a “copy-and-paste” mechanism, DNA transposons move- 
directly as a DNA intermediate by a “cut-and-paste” mode during transposition (Wicker 
et al. 2007, Sinzelle et al. 2009). Eukaryotic DNA transposons encode a single enzyme 
 
Figure 1. Cut-and-paste mechanism of DNA transposon. 
A transposon contains a coding region for the transposase (Tnp, yellow rectangle), flanked 
on both ends by terminal inverted repeats (TIRs, blue arrows). The TIRs are flanked by 
target site duplications (TSDs), characteristic to each transposon family. The transposase 
protein (red sphere) specifically binds to its recognition TIRs at each end of the transposon. 
The transposase excises the transposon by cleaving the DNA at the ends of the TIRs 
following formation of a synaptic complex. The transposase recognizes a target site and 
integrates the transposon into the target DNA, upon which the target site gets duplicated. 
(Figure is adapted from Sinzelle, 2009) 
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called transposases to carry out the “cut-and-paste” transposition process (Lampe et al. 
1996, Sinzelle et al. 2009) (Figure 1). Two functional domains are common in the DNA 
transposases: an N-terminal DNA-binding domain (DBD) that recognizes and binds to the 
terminal inverted repeats (TIR) on the transposon ends in a sequence-specific manner 
and a C-terminal catalytic domain that catalyzes both the DNA cleavage and strand 
transfer steps during transposition (Sinzelle et al. 2009). In the human genome, more 
than 380,000 DNA transposon copies have been identified and belong to 125 different 
families, accounting for approximately 3% of the whole genomic DNA (Lander 2001, 
Jurka et al. 2005, Bao et al. 2015). These human DNA transposons represent seven out 
 
Figure 2. Summary of the activity of human DNA transposons through primate evolution. 
Solid triangles indicate different evolutionary time points when DNA transposable families 
were inserted in the human genome. 125 known human DNA transposable element 
families can be classified into three categories (from left to right): eutherian-wide (80-150 
My), primate specific (65-80 My), and anthropoid specific (40-65 My). No DNA transposable 
elements were found to be active after the emergence of New World Monkeys. My: million 
years. (Figure is adapted from Pace and Feschotte, 2007) 
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of ten known superfamilies of eukaryotic DNA transposons (Jurka et al. 2005).  
The evolutionary history of the human DNA transposons over the course of 
mammalian and primate evolution was analyzed comprehensively by Pace and 
Feschotte, using three independent computational methods to determine the average 
age of all 125 DNA transposon families identified in the human genome (Pace and 
Feschotte 2007). According to their analysis, eighty-five families were traced back to 80 
million years ago (Mya), before the split of a primate ancestor from other eutherians (i.e. 
placental mammals). The remaining 40 DNA transposon families are primate-specific 
families and account for approximately 38 Mb of DNA in the human genome. Early 
primate evolution (65-80 Mya), that is after the divergence of a primate ancestor from 
the closest non-primate eutherian clades (mouse, rat, and rabbit) but prior to the 
emergence of prosimian primates (about 63 Mya), was a period of intense activity for 
DNA transposons, with the result that about 74,000 DNA transposons were inserted and 
fixed in the human genome (about 33 Mb of DNA). During the next phase of the primate 
radiation (40-65 Mya), i.e. after the split of prosimians, but prior to the emergence of 
New World monkeys, approximately 2,300 human DNA transposons were integrated 
during this period. However, there were no DNA transposon families significantly 
younger than the divergence of New World monkeys, approximately 40 Mya (Figure 2). 
Thus, the last active DNA transposon families have long been extinct and no functional 
DNA transposons are found in the human genome (Pace and Feschotte 2007). 
4 
B. Hsmar1 discovery history and resurrection 
As transposable elements can jump from one place to another in the genome, 
transposon insertion is the main cause of mutations in many animals. Insertion of Tc1 
(Transposon Caenorhabditis elegans number 1) causes gene inactivation in several 
strains of C. elegans (Eide and Anderson 1985). Since the discovery of the Tc1 element, 
related elements discovered in other species were found to be homologous to Tc1. The 
best characterized example is the mariner element, first identified in Drosophila 
mauritiana (Jacobson et al. 1986, Jacobson 1990). Members of the Tc1/mariner 
superfamily of DNA transposons are found in a variety of organisms, ranging from fungi 
to humans (Robertson 1993, Robertson 1995, Robertson and Lampe 1995, Plasterk 1996, 
Robertson and Martos 1997, Robertson and Zumpano 1997, Lampe et al. 1999). 
Human Tc1/mariner elements account for approximately one-third of all human 
DNA transposon copies (Smit and Riggs 1996, Smit 1999, Lander 2001). About two 
decades ago, researchers from several groups independently identified two quite 
different families of mariner elements in the human genome (Morgan 1995, Oosumi et 
al. 1995, Smit and Riggs 1996, Robertson and Martos 1997, Robertson and Zumpano 
1997): Hsmar1 (Homo sapiens mariner 1) (Robertson and Zumpano 1997) and Hsmar2 
(Homo sapiens mariner 2) (Robertson and Martos 1997). As the first representative of 
mariner elements recognized in mammalian genomes, the consensus sequence of 
Hsmar1 was constructed by Robertson and colleagues (Robertson and Zumpano 1997). 
The consensus sequence of Hsmar1 is 1287 bp long with 30 bp perfect TIRs and encodes 
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a 343 amino acid mariner transposase (Figure 3). As found in the Tc1/mariner 
superfamily, Hsmar1 encodes only a single protein, the transposase, and is flanked at 
either end by the 30 bp TIRs. The putative Hsmar1 transposase has two functional 
domains: a DNA binding domain and a catalytic domain. The DNA binding domain has 
two helix-turn-helix (HTH) motifs for TIR sequence-specific DNA binding. The catalytic 
domain contains the DD34D motif that is crucial for transposition and is another shared 
feature of eukaryotic mariner elements (Lampe et al. 1996, Lohe et al. 1997, Nowotny 
2009, Montano and Rice 2011). The DD34D motif has first two aspartic acid residues (DD) 
separated from one another by about 90 residues followed by a third aspartic acid 
residue (D) at a distance of 34 residues. 
In the same seminal study, the evolutionary history of Hsmar1 copies in the human 
 
Figure 3. Schematic representation of Hsmar1 transposon DNA and the encoded Hsmar1 
transposase protein. 
The Hsmar1 transposase gene is flanked by two 30-pb terminal inverted repeats (TIRs). 
The Hsmar1 transposase contains a DNA-binding domain with two helix-turn-helix (HTH) 
motifs and a catalytic domain with a DD34D motif. 
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genome was also analyzed in detail by Robertson and colleagues (Robertson and 
Zumpano 1997). Ancestral Hsmar1 was active during early primate evolution period 
(40-65 Mya) (Figure 2) and invaded early primate genomes approximately 50 Mya. 
Movement of the Hsmar1 transposon was ongoing until at least 37 Mya, consistent with 
the evolutionary history of human DNA transposons (Pace and Feschotte 2007) (Figure 
2). As a result of transposition, at least 200 copies of Hsmar1 were integrated in the 
ancestral primate genome. Most of the current Hsmar1 copies in the human genome 
have diverged from the consensus largely (by an average of 7.8% in DNA sequence) and 
have now lost transposition activity. However, one exceptional Hsmar1 copy has been 
remarkably conserved, being only 2.4% divergent from the consensus Hsmar1 gene. 
Interestingly, this Hsmar1 copy retains the entire transposase coding region and is fused 
in-frame downstream of the SET (Suppressor of variegation 3-9, Enhancer of zeste, and 
Trithorax proteins of Drosophila melanogaster) gene coding region, forming a chimeric 
gene called SETMAR, which is the main topic of this thesis. 
At the time the consensus sequence of Hsmar1 was constructed, it was believed 
that a consensus sequence represents an active transposon sequence. When  present 
in cells, this artificial DNA transposon is able to perform transposition. Based on this 
hypothesis, Ivics and colleagues successfully reconstructed two functional transposable 
elements: Sleeping Beauty from fish (Ivics et al. 1997) and Frog Prince from amphibians 
(Miskey et al. 2003). However, the consensus Hsmar1 gene has no transposition function, 
assessed by the same transposition system established for Sleeping Beauty and Frog 
7 
Prince. After phylogenetic analysis, four amino acid substitutions were introduced in the 
consensus transposase protein sequence: C53R, P167S, L201V, and A219C. The resulting 
Hsmar1 transposase protein functions as an active transposable element (Miskey et al. 
2007). 
 
C. The origin of SETMAR and its biological functions 
As Robertson and colleagues revealed, ancestral Hsmar1 was active during the early 
primate evolution period (40-65 Mya, Figure 2) and integrated at least 200 copies of 
Hsmar1 in the ancestral primate genome (Robertson and Zumpano 1997). One 
particular copy of Hsmar1 was fused in-frame to a preexisting SET gene forming a new 
primate chimeric gene SETMAR (Robertson and Zumpano 1997, Cordaux et al. 
2006).Using sequence analysis and phylogenetic comparison, Cordaux and colleagues 
presented a proposed “molecular domestication” process of the Hsmar1 transposase 
gene (Cordaux et al. 2006) (Figure 4). Approximately 50 million years ago, an ancestral 
Hsmar1 transposon integrated downstream of the SET gene. Later, a retrotransposon 
AluSx inserted in the 5’ TIR of the Hsmar1 element, resulting in the deletion of 12 bp of 
the TIR and 4 bp of flanking genomic DNA. At a period of intense activity for Hsmar1 
transposon, the AluSx may have prevented this Hsmar1 copy from mobilizing again since 
both TIRs of transposons are necessary for transposition. The next step towards the 
birth of SETMAR involved the capture and in-frame fusion of the Hsmar1 transposase to 
the SET gene. Compared to tarsier, which only has the SET gene, all examined 
8 
anthropoid lineage SETMAR sequences share a 27-bp genomic deletion that removed 
the stop codon of the SET gene located at the 3’ end of the second SET exon, creating a 
new intron as the current second intron of SETMAR (Figure 4). This process included a de 
 
Figure 4. The Birth of SETMAR. 
Series of proposed molecular events occurred within an evolutionary time window of 
less than 18 million years, after the emergence of the prosimians lineage and before the 
split of anthropoid primates (40-58 million years ago, Mya). A “SET-only” gene, which 
contains two SET exons, is conserved in all non-anthropoid species examined and 
terminated with a stop codon (stop sign). Two SET exons (light green boxes) are 
separated by a single intron (interrupted black line). An ancestral Hsmar1 transposon 
entered downstream of the SET gene in the primate lineage around 50 Mya. The 
transposon shown here contains its TIRs (black triangles) and transposase coding 
sequence (blue box) with stop codon (stop sign). The secondary AluSx retrotransposon 
(red diamond) inserted in the 5’ TIR of the Hsmar1 element, immobilizing this Hsmar1 
copy. The deletion removed the ancestral stop codon of the SET gene (cross sign) and 
allowed the creation of the current second intron of SETMAR, which is represented as a 
dashed red line. This process was made possible by the de novo conversion from 
noncoding sequence to exonic sequence (yellow box). The SETMAR transcript now 
consists of three exons. SET: Suppressor of variegation 3-9, Enhancer of zeste, and 
trithorax proteins of Drosophila melanogaster. (Figure is adapted from Cordaux, 2006) 
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novo conversion of a 77-bp-long previously noncoding sequence into an exonic sequence, 
coding a linker between the end of the former SET protein and the beginning of the 
recruited Hsmar1 transposase. Since this process took place after the divergence of an 
anthropoid ancestor from the prosimian primate clades, the SETMAR gene is only 
present in anthropoid primate lineages (humans, apes, Old World Monkeys, and New 
World Monkeys), but not in prosimians (Tarsier and Galago), and non-primate mammals 
(mouse, rat, dog, and cow).  
In the human genome, the SETMAR gene is mapped on the short arm of 
chromosome 3p26.1, a region which is linked to a number of diseases, such as 
non-Hodgkin's lymphoma, acute leukemia, hereditary prostate cancer, myeloma, and 
myelodysplastic syndromes (Higgins et al. 2004). The SETMAR transcript, which consists 
of three exons, encodes a protein of 671 amino acids (Figure 5) (Note that the NCBI 
 
Figure 5. Schematic diagram of SETMAR protein. 
The SET domain has three motifs: PreSET, SET, and post-SET. The transposase (MAR) 
domain is derived from the Hsmar1 transposase, a member of the mariner superfamily 
of DNA transposon. The DDD/E-like motif in SETMAR is DD34N, with the last amino acid 
substituted from Asp or Glu to Asn. (Note that the NCBI reference sequence 
NP_006506 has been updated to NP_006506.3 with 13 amino acids extending at the 
N-terminal of SETMAR to total of 684 amino acids.) 
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reference sequence NP_006506 has been updated to NP_006506.3 with an additional 
13 amino acids at the N-terminal of SETMAR resulting in a total of 684 amino acids. 
Numbering of amino acids is based on the 671 amino acids version in this thesis). Due to 
accumulating mutations within the transposase domain (Figure 6), SETMAR has lost its 
ability to function as a transposase (Liu et al. 2007, Miskey et al. 2007). However, 
SETMAR is a multi-functional protein which has lysine methylation activity, 
non-homologous end joining DNA repair activity, restart of stalled replication forks, and 
 
 
Figure 6. Protein sequence alignment of SETMAR transposase domain and predicted 
Hsmar1 transposase. 
A. The DNA-binding domain (DBD) of SETMAR has two mutations. B. The catalytic 
domain of SETMAR bares 17 mutations, in which the last amino acid of the DD34D 
motif in Hsmar1, Asp, is substituted to Asn. Green triangles represent DD34D motif in 
the catalytic domain of the mariner element.  
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chromosomal decatenation (Lee et al. 2005, Wray et al. 2009, Wray et al. 2009, De Haro 
et al. 2010, Wray et al. 2010, Carlson et al. 2015). SETMAR is overexpressed in the 
peripheral blood and bone marrow of acute myeloid leukemia (AML) patients as 
compared to that of healthy individuals (Jeyaratnam et al. 2014). 
Evolutionary sequence analysis of SETMAR demonstrated that a continuous 
purifying selection has acted to preserve the DBD but not the catalytic domain of 
SETMAR (Cordaux et al. 2006). Protein sequence alignment of the SETMAR transposase 
domain and the consensus Hsmar1 sequence also demonstrate that only two amino acid 
residues are substituted in the DBD. However, in the catalytic domain, 17 amino acids 
are different from the consensus ancestral sequence (Robertson and Zumpano 1997, 
Cordaux et al. 2006, Miskey et al. 2007) (Figure 6). Importantly, this domain now has a 
DD34N rather than the DD34D motif found in active mariner transposase and thought to 
play an important role in metal binding (Richardson et al. 2009, Goodwin et al. 2010, 
Kim et al. 2014). Consistent with this analysis, biochemical experiments showed that 
SETMAR has retained binding specificity to the putative Hsmar1 TIR DNA, but has lost 
some of its catalytic abilities, resulting in an inactive DNA transposon in humans 
(Cordaux et al. 2006, Liu et al. 2007, Roman et al. 2007).  
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D. Crystal structures of DNA-binding domains of Tc1/mariner superfamily 
transposons 
Members of Tc1/mariner superfamily share many features in terms of transposition 
mechanism. However, the TIRs differ in length and sequence, and the amino acid 
sequences of DBDs vary greatly for different members. For example, the Mos1 
transposon (from D. mauritiana) contains a 28-bp TIR while Tc3 transposon (from C. 
elegans) has a 462-bp TIR at both ends of the cognate element (Watkins et al. 2004, 
Richardson et al. 2009) (Figure 7). The Hsmar1-TIR is a 30-bp DNA sequence (Robertson 
and Zumpano 1997) (Figure 3), within which a core 19-bp region was identified as a 
SETMAR-binding site by EMSA (Electrophoretic Mobility Shift Assay) (Cordaux et al. 2006) 
(Figure 8). Depending on the human genome sequence databases used, the number of 
 
Figure 7. The sequences of the left end TIRs of Tc3, Mos1 and Hsmar1 DNA 
transposons. 
Tc3 has two binding sites separated by about 180 bp at each transposon end. Here 
the 36 bp outer left TIR of Tc3 transposon is shown. Mos1 contains 28 bp imperfect 
TIRs, differing from each other at positions 1, 16, 18, and 26, highlighted in red 
italics. Hsmar1 has two identical TIRs on both ends. The TA target site duplication is 
shown in bold. The cleavage sites are marked by dotted lines. Note the differences of 
the cleavages sites. 
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potential SETMAR-binding sites ranges from 1,500 to 7,000 (Robertson and Zumpano 
1997, Cordaux et al. 2006).  
 
Interestingly, the overall structural fold of the DBD is conserved among all members 
of Tc1/mariner superfamily, such as Mos1 and Tc3 (Watkins et al. 2004, Richardson et al. 
2009) (Figure 9). Strikingly, the DBD of PAX6 (paired box protein 6), which shares a 
common ancestor with the current Tc1 family transposon (Breitling and Gerber 2000), 
shows a similar structural fold as well (Xu et al. 1999) (Figure 9). PAX6 is a 
well-characterized transcription factor that regulates the development of sensory organs 
and brain (Hanson et al. 1994, Azuma et al. 1996).  
 
Figure 8. A 19-bp MAR (transposase domain) binding site (MBS) was identified by EMSA. 
A schematic representation of Hsmar1 transposon is shown on the top, highlighting the 
30-bp 5’ and 3’ TIR sequences. Black arrows show the directions of TIRs. Using purified 
recombinant protein, MBP-fused SETMAR transposase domain, and various TIR 
double-stranded oligonucleotides, Cordaux and colleagues identified a 19-bp MBS, which is 
shown as a shaded sequence. (Figure is adapted from Cordaux 2006) 
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E. Rationale and overview of this thesis 
Although SETMAR retains robust sequence-specific DNA-binding activity, its 
biological significance is still unknown. The overall goal of this thesis is try to understand 
the structural basis of the DNA-binding activity and determine the associated biological 
function of SETMAR. Given that SETMAR retains robust DNA-binding activity and that 
the DNA-binding sites are dispersed throughout the human genome, SETMAR may use 
its ancestral transposase element, the DBD, to regulate expression of genes. To address 
 
Figure 9. Crystal structures of DNA-binding domains of Tc1/mariner superfamily DNA 
transposons. 
The DNA-binding domain contains two HTH motifs that bind to the major groove of 
DNA. A linker connecting two motifs interacts with the minor groove of DNA. PDB IDs 
are in parenthesis. Proteins are rendered as magenta ribbons. DNAs are represented as 
stick models with surface renderings (Xu et al. 1999, Watkins et al. 2004, Richardson et 
al. 2009). 
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this possibility, I determined the crystal structures of the DBD complex with DNA and 
analyzed the protein-DNA interactions. The rationale for designing DBDs derived from 
SETMAR and different DNA sequences for crystallization is discussed along with phasing 
strategies, phasing experiments, model building, crystallographic refinement, and 
analysis of the structures. Using biochemical assays, I characterized the DNA-binding 
affinity and specificity of SETMAR based on the structural analysis. In these experiments, 
the relative contributions of nucleobase-specific interactions were assessed through 
amino acid substitutions in the DBD and base substitutions within the TIR or variant TIR 
sequences that were crystallized. To test the biological function of SETMAR, I conducted 
reporter gene regulation assays and ChIP assays with controls based on the structural 
analysis and DNA-binding results. Collectively, this work supports a role for SETMAR in 
transcriptional regulation. 
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MATERIALS AND METHODS 
A. Protein expression and purification 
For crystallographic studies, two different SETMAR DNA binding domains (DBDs) 
were used, one including residues 329-440, the other 316-440. To construct the first, 
DNA encoding amino acid residues 329-671 was PCR amplified from an existing pET15b 
vector containing the DNA for the SETMAR transposase domain (Goodwin et al. 2010) 
and subcloned into the pET28-derived pSUMO vector (Mossessova and Lima 2000) 
between restriction sites BamH I and Xho I (Primers 329-671_F and 329-671_R). For the 
second plasmid construct, DNA encoding SETMAR residues 316-671 was PCR amplified 
from the pFLAG-CMV4 full-length SETMAR (wt) (Kim et al. 2014) and subcloned into the 
pSUMO vector between BamH I and Xho I restriction sites (Primers 316-671_F and 
316-671_R). Since the PCR amplification region encoding the DBD is short, about 300 bp 
in length, to ease the PCR product purification by gel extraction, the forward primer was 
designed to include the N-terminal 6xHis-SUMO tag coding region in the pET28-derived 
pSUMO vector. Using primers DBD_F and DBD_R, DNA encoding 6xHis-SUMO-SETMAR 
(aa 329-440) or 6xHis-SUMO-SETMAR (aa 316-440) was PCR amplified from cognate 
plasmid encoding SETMAR residues 329-671 or 316-671, respectively and subcloned into 
pSUMO vector between Nco I and Xho I restriction sites. Primers used for subcloning are 
listed in Table 1. Primers  In this thesis, all primers were purchased from Integrated 
DNA Technologies, Inc., (Coralville, IA). The final plasmids were verified by DNA 
sequencing (Genewiz, Inc., South Plainfield, NJ). To optimize crystallization conditions, 
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mutations C381R and C381S were generated individually using the QuikChange II 
site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA). All the primers 
used to create the missense mutations are listed in Table 2. 
For experimental selenomethionine (Se-Met) single anomalous dispersion (SAD) 
phasing purposes, several Met substitutions were introduced to ensure a robust Se 
anomalous signal. Mutations were made by using the QuikChange II site-directed 
mutagenesis kit (Agilent Technologies, Santa Clara, CA) in the 329-440(C381R) plasmid to 
make pET28b-SUMO-SETMAR-329-440(C381R) double mutant constructs (See Table 2 
for primer information). Of these expressed SETMAR recombinant proteins, SETMAR 
(C381R)(I359M)(L423M) was stably expressed in sufficient quantities for crystallization 
experiments. 
Name Sequence (5’—3’) 
329-671_F ATATCGGATCC ATGAAAAT GATGTTAGACAAAAAGCAAATTCG 
329-671_R TATAGCTCGAGTTAATCAAAATAGGAACCATTACAATC 
316-671_F TATATCGGATCCGTGTTCCCCTCCTGCAAGCGATTGA 
316-671_R TATAGCTCGAGTTAATCAAAATAGGAACCATTACAATC 
DBD_F GATATACCATGGGCAGCAGCCATCATCATCATCATC 
DBD_R TATAGCTCGAGTTACACCTTTCCAATTTGCTTCAAATGTC 
Table 1. Primers used for subcloning in the construction of SETMAR expression plasmids. 
Underlined letters are restriction enzyme sites, engineered into the oligonucleotide primers. 
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Name Primer Sequence (5’ – 3’) 
C381R Forward GCAGTGGTGGTTCAAGAAGTTTCGCAAAGGAGATG 
 Reverse CATCTCCTTTGCGAAACTTCTTGAACCACCACTGC 
C381S Forward GCAGTGGTGGTTCAAGAAGTTTAGCAAAGGAGATG 
 Reverse CATCTCCTTTGCTAAACTTCTTGAACCACCACTGC 
L343M Forward AAGCAAATTCGAGCAATTTTCATGTTCGAGTTCAAAATGGGTCGT 
 Reverse ACGACCCATTTTGAACTCGAACATGAAAATTGCTCGAATTTGCTT 
I359M Forward CAGAAACAACTCGCAACATGAACAATGCATTTGGCC 
 Reverse GGCCAAATGCATTGTTCATGTTGCGAGTTGTTTCTG 
L404M Forward GAAGTTGACAACGACCAGATGAGAGCAATCATCGAAG 
 Reverse CTTCGATGATTGCTCTCATCTGGTCGTTGTCAACTTC 
L423M Forward CACGAGAAGTTGCTGAAGAAATGAATGTCAACCATTCTACGGT 
 Reverse ACCGTAGAATGGTTGACATTCATTTCTTCAGCAACTTCTCGTG 
R371A Forward GCCCAGGAACTGCTAACGAAGCTACAGTGCAGTGG 
 Reverse CCACTGCACTGTAGCTTCGTTAGCAGTTCCTGGGC 
S428A Forward GAACTCAATGTCAACCATGCTACGGTCGTTCGACATT 
 Reverse AATGTCGAACGACCGTAGCATGGTTGACATTGAGTTC 
R432A Forward ACCATTCTACGGTCGTTGCACATTTGAAGCAAATTGG 
 Reverse CCAATTTGCTTCAAATGTGCAACGACCGTAGAATGGT 
Table 2. Primers used for site-directed mutagenesis (one letter amino acid codes are used 
for the wild-type and substituted residues). Forward and reverse primers for each site were 
used in the same PCR reaction. Underlined bases represent the mutated codon. 
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Se-Met protein was expressed using an adapted protocol from literature (Van Duyne 
et al. 1993). Rosetta cells (EMD Millipore, Billerica, MA) were grown in M9 minimal 
media. At OD 0.5-0.6, an amino acid cocktail (100 mg/L culture of Lys, Phe and 
Threonine, 50 mg/L culture of Ile, Leu and Val) solution was added to inhibit methionine 
synthesis. Selenomethionine was supplied to the media at a final concentration 60 mg/L. 
The SETMAR proteins were induced in the bacterial cells by addition of 1 mM IPTG and 
grown at 18 ℃ overnight. The Se-Met protein purification protocol was the same as the 
wild-type protein, described below. 
The DBDs of SETMAR used in this study including residues 329-440 or 316-440, and 
various substituted versions of these constructs were expressed in Escherichia coli (E. 
coli) Rosetta cells and purified as previously described (Kim et al. 2014). In brief, 
following lysis and centrifugation, the cell lysate was applied to a Ni-NTA column (Qiagen, 
Valencia, CA) and then subjected to on-column cleavage with the SUMO-specific Ulp1 
protease to remove the N-terminal His-SUMO affinity tag. The eluent was then applied 
to a tandem Q-Sepharose/SP-Sepharose column (GE Healthcare, Marlborough, MA). The 
protein was eluted from the SP-Sepharose column by using a NaCl gradient from 50 mM 
to 1 M, subjected to size exclusion gel chromatography, and then concentrated to 
approximately 5 mM by using 10 kDa molecular weight cutoff concentrators (EMD 
Millipore, Billerica, MA). The protein was stored in 50 mM HEPES pH 7.5, 500 mM NaCl, 
and 1 mM DTT at -80 ℃. 
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For biochemical studies, the full-length SETMAR(wt) gene was cloned into the      
Nde I/Xho I site of pET15b (EMD Millipore, Billerica, MA), which was constructed by a 
former post-doc in our lab, Dr. Kristie D. Goodwin. Into this plasmid, mutations resulting 
in R371A, S428A, and R432A variants of the full-length SETMAR were generated 
individually by using the QuikChange II site-directed mutagenesis kit (Agilent 
Technologies, Santa Clara, CA). The primers used for PCR amplification are listed in Table 
1. The full length SETMAR(wt) and mutants were expressed in Rosetta cells (EMD 
Millipore, Billerica, MA) and induced by culturing at 20 ℃ overnight with 0.1 mM IPTG 
and 50 µM ZnCl2 (Carlson et al. 2015). Cells were lysed in 50 mM phosphate, pH 7.8, 300 
mM NaCl, and 10 mM imidazole by French press (Aminco), and the supernatant after 
ultracentrifugation at 35,000 rpm for 30 min at 4 ℃ was loaded onto a Ni-NTA resin 
column. Eluted protein from the Ni-NTA column was diluted to 60 mM NaCl with no salt 
buffer (50 mM Tris-Cl, pH 7.0, 1 mM DTT) and applied to a Q-Sepharose ion exchange 
column. Elution peak fractions were collected, concentrated, and applied to a gel 
filtration column (Superdex 200 16/60 prep, GE Healthcare, Marlborough, MA) buffered 
with 50 mM Tris-Cl pH 7.0, 500 mM NaCl, and 1 mM DTT. The full length SETMAR(wt) 
and substituted proteins were concentrated using 10 kDa molecular weight cutoff 
concentrators (EMD Millipore, Billerica, MA). Protein was stored in 50 mM Tris-Cl pH 7.0, 
500 mM NaCl, 1 mM DTT buffer at -80 ℃. 
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B. DNA oligonucleotides for crystallization 
The oligonucleotides used in this study were synthesized by Midland Certified 
Reagent Company, Inc. (Midland, TX) on a one micromole scale and purchased in 
gel-purified, desalted form, and used without further purification. In all, eight duplex 
oligonucleotides were screened in crystallization experiments (Figure 11 and Figure 13). 
For the TIR complex, two oligonucleotides, 5’– GGTTGGTGCAAAAGTAATTGCGGTTA –3’ 
and its complementary strand 5’– AACCGCAATTACTTTTGCACCAACCT -3’, were annealed 
to form a 25-mer duplex DNA, TIR2 in Figure 11, which featured overhanging 3’ A and T, 
respectively. Similarly, variant-TIR1 DNA shown in Figure 13 was prepared by annealing 
complementary oligonucleotides 5’- GCAGTGTGCAAAAGTGATTGCGGCTA -3’ and 5’- 
AGCCGCAATCACTTTTGCACACTGCT -3’. For experimental phasing, the underlined “Ts” 
were replaced by 5-BrdU. 
  
C. Crystallization 
All of the variations of the DBD (329-440 (wild-type), 329-440 (C381S), 329-440 
(C381R), and 316-440 (C381S)), were mixed with duplex DNA (5 mM stock) to make a 
final protein:DNA molar ratio of 1:1.2 in 50 mM HEPES pH 7.5, 150 mM NaCl, and 1 mM 
DTT. The resulting protein concentration was 500 µM. The protein-DNA complex was 
incubated on ice for 15 min prior to crystallization. 
Initial crystallization screens were performed using the Art Robbins Gryphon 
crystallization robot (Art Robbins Instruments, Sunnyvale, CA) with 0.6 µL drops (0.3 µL 
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complex plus 0.3 µL reservoir solution) and 60 µL reservoirs in 96 well sitting drop vapor 
diffusion plates (Intelli-Plate 96-3 LVR, HR3-185; Hampton Research, Aliso Viejo, CA). 
Subsequently, all crystals were grown by vapor diffusion in 2 µL (1 µL complex plus 1 µL 
reservoir solution) hanging drops at 20 ℃ suspended over 500 µL of reservoir solution. 
The crystals for data collection were obtained by micro-seeding, cryocooled in a solution 
containing 20% ethylene glycol added to a stabilizing solution, and flash frozen in liquid 
nitrogen before data collection. 
 
D. Data collection and data processing 
Diffraction data were collected at 100 K at the 23-ID-B, 23-ID-D, and 19-ID beamlines 
at the Advanced Photon Source, Argonne National Laboratory. For experimental phasing, 
single-wavelength SAD data sets were collected from BrdU-labeled or SeMet/BrdU 
labeled protein-DNA complex crystals at the bromine or selenium absorption peak 
wavelength, 0.91922 Å and 0.97938 Å, respectively. Diffraction data were processed 
using XDS (McCoy et al. 2007) at 23-ID beamlines or HKL3000 (Minor et al. 2006) at 
19-ID. Statistics for data processing and crystallographic refinement statistics are 
summarized in Table 5.  
 
E. Experimental phasing and structure determination 
For phasing purposes, Se SAD data (TIR complex, Se SAD in Table 5) were collected 
to 2.66 Å for DBD 329-440 (C381R)(I359M)(L423M) complexed with BrdU substituted TIR 
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DNA. Using AutoSol (Adams et al. 2010) primed with the three sites identified in the 
initial phasing experiment described in the Results section, five Se sites were identified; 
phases calculated from these sites resulted in a very interpretable electron density map. 
Autobuild (Adams et al. 2010) functions within AutoSol (Adams et al. 2010) were used to 
obtain a partial model of the DNA and two HTH motifs. A model containing residues 
330-437 and the complete DNA duplex was completed through iterative cycles of model 
building in COOT (Emsley et al. 2010) and crystallographic refinement in REFMAC 
(Murshudov et al. 1997, Winn et al. 2011) and PHENIX (Adams et al. 2010). Although Br 
SAD datasets collected for the DBD complexed with BrdU-containing DNA crystals did 
not prove useful for phasing purposes, they were useful in confirming the positions of 
the BrdU in the DNA model. The positions of the SeMet residues were confirmed by 
anomalous difference Fourier analysis.  
Diffraction data for the TIR complex (TIR complex, High Resolution in Table 5), 
including DBD 329-440 (C381R) (I359M) (L423M) complexed with brominated TIR DNA 
were collected to 2.37 Å. The structure was determined by molecular replacement in 
PHASER (McCoy et al. 2007, Winn et al. 2011) using the above model derived from the 
Se SAD experimental electron density map as the search model. A final refined model 
was obtained following iterative cycles of model building in COOT (Emsley et al. 2010) 
and refinement in PHENIX (Adams et al. 2010) and BUSTER (Bricogne G. and Roversi P 
2016) using individual atomic coordinates and B-factors, maximum likelihood targets, 
and TLS parameters. Based on analysis from the TLS Motion Determination server 
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(http://skuld.bmsc.washington.edu/~tlsmd/index.html)(Painter and Merritt 2006, 
Painter and Merritt 2006), both TIR and variant-TIR complexes can be partitioned into 6 
TLS groups: chain A 331-396, chain A 397-437, chain B 1-15, chain B 16-26, chain C 1-10, 
and chain C 11-26. 
The crystal structure of the DBD protein containing residues 316-440 (C381S) 
complexed with brominated variant-TIR DNA (Variant-TIR complex in Table 5) was 
determined at 3.07 Å by molecular replacement as implemented in PHASER (McCoy et al. 
2007, Winn et al. 2011) using the refined TIR complex as the search model and refined 
similarly to the TIR complex using both REFMAC (Murshudov et al. 1997, Winn et al. 
2011) and PHENIX (Adams et al. 2010).  
 
F. Fluorescence anisotropy assays (FA assay) 
FA assays were conducted as described previously (Kim et al. 2014). In brief, 20 nM 
rhodamine-labeled DNA probe was incubated with varying concentrations of protein in a 
50 µl reaction mixture buffered in 50 mM HEPES, pH 7.0, 150 mM NaCl and 1 mM DTT. 
Oligonucleotides were ordered from Midland Certified Reagent Company, Inc. (Midland, 
TX). We measured fluorescence anisotropy data by using the Envision[TM] 2102 Multilabel 
Plate Reader (PerkinElmer Life Science, Waltham, MA) in the Chemical Genomics Core 
Facility of Indiana University School of Medicine. KD values were calculated by fitting the 
data to a one-site binding saturation ligand binding curve (SigmaPlot, version 11.2). 
Every titration experiment was conducted three times independently with triplicate 
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readings each time. A 5’- (rhodamine)(C6 amino) – AACCGCAATTACTTTTGCACCAACCTAA 
-3’ oligonucleotide was annealed to its complementary sequence to make the Hsmar1 
TIR duplex DNA probe. For the Hsmar1 variant TIR duplex DNA probe, an oligonucleotide 
5’– (rhodamine)(C6 amino) – AGCCGCAATCACTTTTGCACACTGCTAA –3’ was annealed to 
its complementary sequence. The DNA sequence of the Hsmar1 variant TIR probe is the 
same as the one in the variant-TIR complex. 
 
G. Protein-DNA binding competition assay 
Competition assays were performed by titrating a protein-rhodamine DNA solution 
with an unlabeled DNA duplexes obtained from Midland Certified Reagent Company, Inc. 
(Midland, TX). Unlabeled DNA duplexes were prepared and annealed as described above 
for the fluorescently labeled oligonucleotides. Duplexes that successfully competed with 
the labeled probe displaced the fluorescent probe resulting in a loss of fluorescence 
anisotropy. For this study, we used 300 nM FL SETMAR (wt) with 20 nM DNA probe. The 
concentrations of protein and DNA probe were determined from the binding assay in 
which 70% of the saturated fluorescence anisotropy was measured. The buffer used in 
this assay was the same as above: 50 mM HEPES, pH 7.0, 150 mM NaCl and 1 mM DTT. 
The data generated from this analysis were plotted as a function of anisotropy against 
log of the unlabeled DNA concentration. DNA sequences used in this competition assay 
are listed in Table 6. 
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H. Luciferase Reporter Assays 
To construct a luciferase reporter plasmid, five tandem repeats of Hsmar1 TIR 
sequence were cloned in upstream of an SV40 promoter of the pGL3-Promoter Vector 
(Promega, Madison, WI; cat. E1761) at an Xho I site, generating pGL3-promoter-5xTIR. 
The tandem repeat DNA sequence was purchased from IDT gene synthesis, shown in 
Figure 10. The expression plasmid, pFLAG-CMV4-SETMAR (wt), contains full-length 
SETMAR (aa 1–671) with a FLAG epitope tag at the N terminus (Sigma-Aldrich, St. Louis, 
MO). Using the QuikChange II site-directed mutagenesis kit (Agilent Technologies, Santa 
Clara, CA), pFLAG-CMV4-SETMAR (R371A) was constructed using the above wild-type 
plasmid as a template. 
In collaboration with Mike Fusakio in Dr. Ron Wek’s lab, HEK293T cells were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS, and 
Penicillin/Streptomycin (5ml in 500mL) (HyCloneTM, GE Healthcare, Marlborough, MA; 
 
Figure 10. Schematic diagram of five tandem repeats of Hsmar1 TIRs in the 
pGL3-promoter luciferase vector. 
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cat. SV30010) at 37℃ in a 5% CO2 incubator. Cells were transfected using FuGENE 6 
transfection reagent (Promega, Madison, WI). For one well of a 6- well cell culture plate, 
each transfection mixture contained 1 μg of luciferase reporter plasmid, 1 μg of 
expression plasmid, and 0.05 μg of pRL-CMV Renilla luciferase plasmid as an internal 
control. After 48 h, the transfected cells were lysed and assayed using the 
Dual-luciferase reporter assay system (Promega, Madison, WI). The firefly and Renilla 
luciferase activities were measured by 20/20n Luminometer (Turner BioSystems, 
Sunnyvale, CA). Relative luciferase activity was calculated as the firefly luciferase divided 
by Renilla luciferase. The assays were performed three times with triplicate 
measurements for each. Statistical significance was determined by Student’s t-test in 
GraphPad (Prism 6). 
 
I. Chromatin immunoprecipitation (ChIP) assay 
For one 10-cm cell culture dish, HEK293T cells were transfected with 6 μg of 
expression plasmid pFLAG-CMV4-SETMAR (wt) using FuGENE 6 transfection reagent 
(Promega, Madison, WI). One immunoprecipitation required 10 to 15 million cells. After 
48 h, the transfected cells were fixed in 1% formaldehyde by adding 650 µL of 16% 
formaldehyde (Thermo Scientific, Waltham, MA; cat. 28906) to each 10-cm culture dish 
containing 10 mL medium. The cross-linking of proteins to DNA was carried out at room 
temperature for 10 min and was stopped by adding 1 mL of 10X glycine to cells at a final 
concentration of 125 mM. After washing twice with PBS, two cell dishes (about 10-15 
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million cells) were scraped and combined into one 1.5 mL tube. Cells were resuspended 
in 1.2 mL lysis buffer containing 50 mM Tris-pH7.5, 150 mM NaCl, 5 mM EDTA, 1% 
TritonX-100, and protease inhibitors (1 mM PMSF, 1X protease inhibitor cocktail Set V 
(EMD Millipore, Billerica, MA; cat. 539127). Chromatin in the lysate was sonicated using 
a Bioruptor 300 (Diagenode, Denville, NJ) to an average length of 200-500 bp as 
determined by agarose gel electrophoresis. The sonication condition was 30 cycle 
number, 30 seconds time on/off at high power. Immunoprecipitation (IP) was performed 
using Anti-FLAG M2 affinity agarose (Sigma-Aldrich, St. Louis, MO; cat. A2220) for 
SETMAR and mouse IgG-agarose (Sigma-Aldrich, St. Lois, MO; cat. A0919) for a negative 
control group. Before IP, 40 µL (50% slurry) was washed with buffer containing 50 mM 
Tris-pH7.5, 150 mM NaCl, 5 mM EDTA and 1% TritonX-100. For IP, 500 µL of supernatant 
of the sheared chromatin was added to the washed agarose beads and rotated 
overnight at 4 ℃. For each sample, agarose beads were collected at 1,000 rpm and 
washed three times in low salt wash buffer (50 mM Tris-pH7.5, 150 mM NaCl, 5 mM 
EDTA, and 1% TritonX-100), one time in high salt wash buffer (50 mM Tris-pH7.5, 500 
mM NaCl, 5 mM EDTA, and 1% TritonX-100), and then one time in TE buffer (pH 8.0). 
Following 5 min of mild shaking at 4 ℃, each wash was centrifuged at 1,000 rpm at 4 ℃, 
and the supernatants were discarded. Immunoprecipitated complexes were incubated 
with 150 µL of 0.1 M glycine (pH 3.5) for 5 min at room temperature. The resin was 
centrifuged for 30 seconds at 1,000 rpm at room temperature to elute complexes. The 
supernatant was transferred to a new tube containing 15 µL of 10X neutral buffer (0.5 M 
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Tris pH 7.5, 1.5 M NaCl). To reverse crosslinks and digest protein, 2 µL proteinase K (20 
mg/mL, Ambion, Foster City, CA; cat. AM2546) was added and incubated at 65 ℃ 
overnight. DNA samples were purified by using a PCR purification kit (Qiagen, Valencia, 
CA) and eluted with 30 µL EB buffer in the final step. 
To detect SETMAR enrichment in the TOPBP1 promoter region, primer pairs, which 
amplify the TOPBP1 promoter region (from -188 to -46 bp), were 5’- 
CGTTTGACATTTCCGCTCTTCTGCTGC -3’ and 5’- CCTACCCCAAAGCAAACGCTGGAGAA -3’. 
PCR mixtures contained 5 µL of IP DNA, 2 µL of primer pairs (10 µM of each), 10 µL of 2X 
SYBR-Green Reaction Mix (Bioline USA Inc, Taunton, MA) and 3 µL ddH2O in a total 
volume of 20 µL. qPCR was performed at 95 ℃ for 3 min, 40 cycles of denaturation (95 ℃ 
for 15 sec) and annealed/extended at 60 ℃ for 60 sec. The signal ratio was calculated 
using 2^(C[T] IgG - C[T] Anti_FLAG) and obtained from three independent ChIP 
experiments. 
 
J. Plasmid DNA immunoprecipitation 
The above ChIP protocol was modified for plasmid DNA immunoprecipitation. 
HEK293T cells were transfected pGL3-promoter-5xTIR and pFLAG-CMV4-SETMAR (wt). 
The cross-linking, sonication and immunoprecipitation steps are the same as above. 
qPCR was used to detect binding of SETMAR to the plasmid DNA. PCR mixtures 
contained 5 µL of IP DNA, 2 µL of primer pairs (10 µM of each), 10 µL of 2X SYBR-Green 
Reaction Mix (Bioline USA Inc, Taunton, MA) and 3 µL ddH2O in a total volume 20 µL. 
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Primer sequences 5’- GAGCTCTTACGCGTGCTAG -3’, and 5’- 
TAATTGAGATGCAGATCGCAGAT -3’, were designed to anneal to the multi-cloning sites of 
pGL3-promoter flanking the 5xTIR binding site (Promega, Madison, WI). qPCR was 
performed at 95 ℃ for 3 min, 40 cycles of denaturation (95 ℃ for 15 sec) and 
annealed/extended at 60 ℃ for 60 sec. The signal ratio was calculated using 2^(C[T] IgG - 
C[T] Anti_FLAG) and obtained from three independent experiments. 
 
K. Western blot analysis 
In collaboration with Mike Fusakio in Dr. Ron Wek’s lab, western blot analysis was 
conducted to evaluate the protein expression stability of mutant SETMAR(R371A) in 
HEK293T cells, as described previously (Teske et al. 2013). Cells were transfected with 
pFLAG-CMV4-SETMAR (wt) or pFLAG-CMV4-SETMAR (R371A). After 48 h, the 
transfected cells were lysed in a RIPA-buffered solution containing 50 mM Tris-HCl (pH 
7.9), 150 mM sodium chloride, 1% Nonidet P-40, 0.1% SDS, 100 mM sodium fluoride, 
17.5 mM β-glycerophosphate, 0.5% sodium deoxycholate, and 10% glycerol 
supplemented with EDTA-free protease inhibitor cocktail tablet (Roche, Indianapolis, IN). 
Protein was separated via SDS–polyacrylamide gels (SDS-PAGE). Primary antibodies used 
in this study included those against β-actin (A5441; Sigma-Aldrich, St. Louis, MO) and 
Anti-FLAG M2 (F1804; Sigma-Aldrich, St. Louis, MO) were prepared at a concentration of 
1:500 in 5% milk powder in PBS. Secondary antibodies were purchased from Bio-Rad 
(Hercules, CA). FLAG protein was detected through chemiluminescence as previously 
31 
described (Teske et al. 2013). Actin protein was recorded using the Odyssey infrared 
imaging system (LI-COR Biosciences, Lincoln, NE). 
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RESULTS 
A. Variation of the protein and DNA components of the complex 
The ability to crystallize protein-DNA complexes involving a small DBD relative to the 
size of the DNA will necessarily depend on optimizing both the protein and DNA 
components of the complex. In this study, four different variants of the DBD and eight 
different oligonucleotides were screened in crystallization trials. Variants of the DBD 
include the following: wild-type 329-440, 329-440(C381S), 329-440(C381R), and 
316-440(C381S). The initial DBD including the wild-type SETMAR sequence was defined 
 
Figure 11. Hsmar1 TIR based DNA sequences used for crystallization. 
The left end Hsmar1 TIR sequence is shown on the top. The italic TA is the characteristic target 
site duplication in the Tc1/mariner transposon superfamily. Four different TIR-derived 
sequences were used for initial crystallization trials. The core 19-bp binding site is in gray. In 
TIR2, the bold Ts represent positions for which T was replaced by 5-BrdU in the Br-DNA 
duplexes. The overhang nucleotides in boxes are designed for facilitating crystal packing.  
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as residues 329-440 based on a sequence comparison with the related transposase, 
Mos1, and was complexed to four different TIR-containing DNA duplexes for 
crystallization trials. The four oligonucleotides shown in Figure 11 were designed based 
on prior knowledge of the Hsmar1 binding site within the TIR (Cordaux et al. 2006) and 
the available crystal structures Tc3 and Mos1 complexed with DNA (Watkins et al. 2004, 
Richardson et al. 2009). In these initial designs, the placement of the 19 bp mariner 
binding site (MBS) relative to the ends of the oligonucleotides and the length of the 
duplex regions were varied. The DNA sequences include two 24-mer duplexes with one 
5’ overhanging nucleotide on each strand, TIR1 and TIR3, and two 25-mer duplexes with 
one 5’ overhanging nucleotide, TIR2 and TIR4. In TIR1, the 19 bp MBS was placed 
centrally with three additional 5’ nucleotides from the TIR sequence and two 
nucleotides 3’ of the recognition element. TIR3 included two 5’ nucleotides and three 3’ 
nucleotides on either side of the MBS. TIR2 included four 5’ nucleotides and two 3’ 
nucleotides, and TIR4 two 5’ nucleotides and four 3’ nucleotides. 
To identify crystallization conditions, approximately 400 conditions contained within 
Index, Natrix and Natrix2, Crystal Screen and Crystal Screen 2, and PEG-ion and PEG-ion2 
kits from Hampton Research, Inc. were screened. Crystals were obtained for the complex 
of wild-type DBD with TIR2 from the Index G2 condition (Hampton Research), which 
contains 0.2 M Li2SO4, 0.1 M Bis-Tris pH 5.5, and 25% w/v PEG 3350 (Figure 12 A). During 
optimization of this crystallization condition, we found that addition of TCEP, or 
tris(2-carboxyethyl)phosphine, improved the crystal size and appearance (Figure 12 B). 
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However, the crystals grown in the presence of TCEP only diffracted X-rays to about 8 Å. 
Since TCEP is highly effective at keeping sulfhydryls reduced, limiting disulfide bond 
formation, we then looked for cysteine residues in the protein sequence that might form 
intermolecular disulfide bonds during the crystallization process and identified one Cys 
residue, C381, within this DBD. The equivalent position in Mos1 is Lys54, which is solvent 
exposed in the crystal structure of the paired end Mos1 complex (Richardson et al. 2009). 
Interestingly, it was this same cysteine that was substituted with Arg, together with 
other critical substitutions, to reconstruct an active Hsmar1 transposase from the 
 
Figure 12. Crystal images of initial crystallization trials. 
(A) 329-440(wt) with TIR2. (B) 329-440(wt) with TIR2 with TCEP additive. (C) 
329-440(C381S) with TIR2. (D) 329-440(C381S) with variant TIR1. (E) 316-440(C381S) with 
variant TIR1. (F) 329-440(C381R) with TIR2. 
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consensus sequence (Miskey et al. 2007). Thus, we introduced two different 
substitutions for C381, C381S, representing a relatively conservative substitution, and 
C381R, as found in the revertant SETMAR, for further crystallization trials.  
Crystals of DBD 329-440(C381S) complexed with TIR2 were similar in morphology to 
the wild-type DBD:TIR2 complex grown in the presence of TCEP (Figure 12 B and C). The 
crystallization condition Index E11 (Hampton Research) contained 25% poly (acrylic acid 
sodium) 5100, 0.10 M HEPES pH7.5, 0.02M MgCl2. A very small cryocooled crystal 
diffracted X-rays to 4 Å and belonged to the monoclinic space group C2, with unit-cell 
parameters a=78.7, b=168.6, c=74.9 Å, β=108.35°. In this case, attempts to cryocool 
larger crystals were unsuccessful with diffraction limited to low resolution.  
Another variable screened with the goal of improving the crystals was the sequence 
of the DNA used for crystallization. Changes in the nucleotide sequence of the 
oligonucleotide duplexes were introduced by attempting to retain critical nucleobases 
identified in the EMSA analysis (Cordaux et al. 2006) while varying others that might not 
be critical for SETMAR binding (Figure 13). Our screen of these variant-TIR 
oliognucleotides complexed with 329-440(C381S) produced crystals in the Natrix A2 
condition (0.01 M Magnesium acetate, 0.05 M MES pH5.6, 2.5 M ammonium sulfate) 
(Figure 12 D). However, cryocooling of the crystals proved problematic as indicated by 
smeared diffraction patterns that extended only to low resolution.  
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Realizing that the transposase is fused to the C-terminus of a SET domain, it 
occurred to us that additional residues derived from the linking region between the SET 
and transposase domains might be involved in DNA-binding. Accordingly, a DBD 
including residues 316-440 with the C381S substitution was screened with both TIR and 
variant TIR-containing oligonucleotides. Crystals were obtained for a complex including 
316-440(C381S) with variant TIR 1 in 0.10 M magnesium formate and 15% PEG3350 
(Figure 12 E). Crystals for this complex diffracted to 3.15 Å and belonged to space group 
C2221 with cell dimensions of a=72.23 Å, b=164.39 Å, c=67.96 Å. 
 
Figure 13. Hsmar1 TIR based DNA sequences used for crystallization. 
The left end Hsmar1 TIR sequence is shown on the top. The italic TA is the characteristic 
target site duplication in Tc1/mariner transposon superfamily. Four variant-TIR sequences 
were used for crystallization trials. The core 19-bp binding site is in gray. The underlined 
bases are mutated from the Hsmar1 TIR sequence. In variant-TIR1, the bold Ts represent 
positions for which T was replaced by 5-BrdU in the Br-DNA duplexes. The overhang 
nucleotides in boxes are designed for facilitating crystal packing. 
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In a parallel effort, we screened the 329-440(C381R) DBD complexed with both TIR 
and variant-TIR sequences. Crystals were obtained for a complex with TIR2 from 
Hampton Research Natrix D9, which contains 0.025 M magnesium sulfate hydrate, 0.05 
M Tris hydrochloride pH 8.5, and 1.8 M ammonium sulfate (Figure 12 F). Crystals 
diffracted to 4 Å and belong to space group C2221 with cell dimensions of a=74.727Å, 
b=168.760 Å, and c=72.191 Å. No promising crystals were obtained from 
329-440(C381R) with variant-TIR 1 complex. 
 
 
 
 
Protein 
construct 
329-440 (wt) 329-440 
(C381S) 
329-440 
(C381S) 
316-440 
(C381S) 
329-440 
(C381R) 
DNA TIR 2 TIR 2 variant-TIR 1 variant-TIR 1 TIR 2 
Crystallization 
condition 
0.2 M lithium 
sulfate 
0.1 M Bis-Tris 
pH5.5 
25% w/v PEG 
3350 
25%   poly 
(acrylic acid 
sodium) 5100 
0.10M  
HEPES pH7.5 
0.02M  
MgCl2 
0.01 M 
magnesium 
acetate 
0.05 M MES 
pH5.6 
2.5 M 
ammonium 
sulfate 
0.10 M 
magnesium 
formate 
15% PEG3350 
0.025 M 
magnesium 
sulfate hydrate 
0.05 M 
Tris-HCl pH 8.5 
1.8 M 
ammonium 
sulfate 
Space group N/A C2 N/A C2221 C2221 
Cell 
parameters 
N/A a=78.7 Å 
b=168.6 Å 
c=74.9 Å 
β=108.35° 
N/A a=72.23 Å 
b=164.39 Å 
c=67.96 Å 
a=74.727Å 
b=168.760 Å 
c=72.191 Å 
Table 3. Summary of the initial crystals. N/A: not available 
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B. Considerations in phasing strategies  
Although the sequence of the SETMAR’s DBD is 30 % identical to that of Mos1, the 
DNA sequence that it recognizes makes up 54% of the mass of the complex and shares 
no sequence similarity to the Mos1 sequence. Thus, we pursued two single anomalous 
dispersion (SAD) phasing strategies for selenomethionine-labeled protein (SeMet SAD) 
and brominated DNA (Br SAD). For experimental SeMet SAD phasing purposes, several 
Met substitutions were introduced to ensure a robust Se anomalous signal. Since three 
out of the four intrinsic Met residues are clustered on the N-terminus and are likely to 
be disordered, we sought to improve the Se signal by increasing the number of ordered 
SeMet residues within the protein. Through a sequence comparison with Mos1, we 
identified amino acid residues that might be well-ordered and tolerate substitution to 
 
Figure 14. The pairwise sequence alignment of Mos1 transposase and SETMAR DNA-binding 
domains, 1-113 and 329-440, respectively. 
The intrinsic Met residues are marked by green triangles. Residues substituted with Met for 
phasing by SeMet SAD are highlighted by blue dots. Secondary structure elements of Mos1 
transposase DNA-binding domain (PDB ID: 3HOT) are shown above the alignment. (The 
figure was created with ESPript 3.0) 
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Met within both predicted HTH motifs in SETMAR (Figure 14). Desirable sites for 
introduction of Met include those that are conserved as hydrophobic residues Leu, Met, 
or Ile in both sequences. Four doubly mutated constructs were made including the 
following pairs: L343M and L404M, L343M and L423M, I359M and L404M, and I359M 
and L423M. The double mutant protein constructs were introduced into the 
329-440(C381R) plasmid. Of these, SETMAR (C381R)(I359M)(L423M) was stably 
expressed in sufficient quantities for crystallization experiments. With the introduction 
of two additional Mets, there are a total of six possible Se sites in the SeMet-labeled 
protein (Figure 14).  
For Br SAD experimental phasing, two thymidine sites (dT) were replaced with Br-dU 
in two strands for TIR2 and within a single strand for variant TIR1, with the criteria that 
those sites were not symmetrically positioned within the oligonucleotide and would not 
be expected to be in direct contact with the protein based on the prediction (Figure 15). 
Unexpectedly, crystals grown for DBD complexes with brominated oligonucleotides were 
uniformly of better quality than those grown for the corresponding complex with the 
natural DNA sequences. As a consequence, all of the crystals used for phasing 
experiments contained brominated oligonucleotides. Although Br SAD data were 
collected for DBD 316-440(C381S) complexed with variant brominated-TIR1 and DBD 
329-440(C381R) complexed with brominated TIR2, attempts to identify Br sites were not 
successful and thus no phasing information was obtained. 
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Figure 15. Predicted BrdU replacement sites based on Mos1 DNA-binding domain 
complex with Mos1 TIR model (PDB ID: 3HOT). 
(A) Predicted model for TIR2 DNA. Two sites are located in different strands, shown 
as blue and yellow arrows. (B) Predicted model for variant-TIR1 DNA. Both sites are 
located in the same strand, shown as blue arrows. For DNA sequences, see Figure 
11 and Figure 13. 
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C. Low resolution Se SAD phasing 
Two datasets were collected at the Advanced Photon Source beamline 23-ID-D 
for SeMet derivatized DBD 329-440(C381R)(I359M)(L423M) complexed to brominated 
TIR DNA, one to 3.75 Å and the other to 3.24 Å resolution (Table 4). Attempts to identify 
Se sites from either dataset alone were not successful. Therefore, using the CCP4 (Winn 
et al. 2011) program BLEND (Foadi et al. 2013), the two SeMet SAD datasets were 
merged producing a 4.17 Å dataset (Table 4). Three of the possible six sites were 
identified using the program AutoSol as implemented in PHENIX (Adams et al. 2010), 
namely I359M, L423M and the intrinsic M348. These sites were used to phase an 
electron density map at 4.17 Å. The electron density of the DNA phosphate backbone 
was identified in this map, and an initial model for the DNA phosphate backbone and a 
polyalanine model for the two HTH motifs were built (Figure 16).  
Data set C10 C11 Merged 
X-ray source GM/CA 23-IDB GM/CA 23-IDB GM/CA 23-IDB 
X-ray detector MARCCD MARCCD MARCCD 
Wavelength(Å) 0.97945 0.97945 0.97945 
Space group C2221 C2221 C2221 
a, b, c (Å) 72.41, 167.01, 66.61 71.63, 166.29, 65.40 72.02, 166.65, 66.01 
Resolution range (Å) 47.04--3.75 83.14—3.24 46.71—4.17 
Completeness (%) 98.0 99.6 99.9 
Redundancy 11.3 11.0 21.3 
Mean I/σ(I) 13.0 10.8 20.5 
Rpim or Rmeas 0.050 0.067 0.038 
Table 4. Data statistics of 329-440(C381R)(I359M)(L423M) complex with TIR DNA. 
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D. Crystal structures of SETMAR bound to two different DNA sequences reveal  
a conserved set of interactions  
Having completed the above phasing experiments, we optimized the crystallization 
of SeMet-derivatized 329-440(C381R) (I359M) (L423M) complexed to TIR DNA (the TIR 
complex) and ultimately obtained crystals that diffracted to higher resolution. An initial 
structure of the TIR complex was determined by Se-SAD phasing at 2.66 Å, figure of 
merit 0.38 for initial phasing, (Figure 17 A) with well-defined electron density for 
residues 330-437 and the entire DNA duplex. Anomalous difference Fourier analysis was 
used to confirm the location of five Se-Met sites in the model (Figure 17 B). This 
 
Figure 16. The 4.17 Å experimental electron density map contoured at 2.0 sigma, using 
merged SeMet SAD data set. 
(A) SAD map shows DNA backbone density. (B) An initial model of the DNA phosphate 
backbone fits into the SAD map contoured at 2 sigma. 
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structure was then used as the search model to determine a higher resolution TIR 
complex structure and the variant TIR complex structure by molecular replacement. In 
this thesis, we present the crystal structures of SETMAR DBD bound to two different 
25-mer DNA duplexes: DBD 329-440(C381R) complexed to TIR DNA (the TIR complex) at 
2.37 Å resolution and DBD 316-440(C381S) complexed to variant-TIR DNA (the variant 
TIR complex) at 3.07 Å. 
 
Figure 17. Se-SAD phasing. 
(A) The experimental electron density map of TIR complex, from selenium single 
wavelength anomalous diffraction (Se-SAD) phasing using data to 2.66 Å (blue mesh, 
contoured at 1.6 sigma). The electron density map is superimposed on the refined 
model. The protein backbone atoms are shown in red and the DNA backbone atoms 
are shown in yellow. (B) Anomalous difference Fourier map of the SeMet-labeled TIR 
complex, superimposed with the backbone trace of the refined model (green for 
protein and orange for DNA). The map is contoured at 4 sigma (red). (SeMet 331, 332, 
348, 359, and 423 are displayed as ball-and-stick side chain models (magenta color).  
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 TIR complex (Se-SAD) TIR complex (High Res.) Variant-TIR complex 
PDB ID - 5KWT 5KWU 
Data Collection    
Space group C2221 C2221 C2221 
Cell dimensions    
a, b, c (Å) 70.09, 166.04, 66.09 70.98, 166.17, 66.05 72.10, 164.21, 68.16 
  α,β,γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 
Wavelength (Å) 0.97938 0.97938 0.91922 
Resolution (Å) 29.42—2.66 27.70—2.37 (2.46—2.37) 82.11---3.07 (3.11—3.07) 
Rpim 0.027 0.024 (0.256) 0.050 
Mean I/σ(I) 18.4 21.9 (2.3) 11.5 (1.87) 
Completeness (%) 99.5 99.7 (99.1) 97.7 (91.3) 
Redundancy 7.7 4.3 (4.0) 8.3 (7.5) 
Refinement    
Resolution (Å) - 27.70---2.37 82.11---3.07 
No. reflections - 16176  
Rwork / Rfree (%) - 21.10 / 23.50 22.45 / 25.44 
No. atoms -   
  Protein - 884 870 
  DNA - 1060 1060 
  Water - 13 0 
B factors -   
  Protein - 73.23 126.88 
  DNA - 89.69 158.19 
  Water - 71.07 - 
r.m.s. deviation -   
Bond lengths (Å) - 0.013 0.011 
Bond angles (°) - 1.34 1.60 
Table 5. Data collection and refinement statistics. 
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The structures reveal a dimeric complex created by crystallographic symmetry in 
which each DBD comprises two HTH motifs connected by a 17 aa linker (residues 
384-400) containing two AT hook elements bound to a 25mer DNA duplex (Figure 18). 
Each HTH motif contains three α-helices with the third α-helix, the recognition α-helix, 
in each HTH motif (α3 or α6) bound to the major groove of the DNA (Figure 18). 
Interactions with the minor groove of the DNA involve the AT hook elements within the 
linker between α3 and α4 helices. The two HTH domains differ in size with HTH1 
comprising 47 and HTH2 37 residues and therefore in structure with a rmsd of 1.7 Å for 
superpositioning of 34 Cα atoms. The larger of the two HTH motifs, HTH1, dimerizes 
through interactions of residues F344, F363, and I341 from α1 and α2 helices burying 
1610 Å2 in the interface (Figure 19). In the smaller HTH2 domain, α4 and α5 are both 
shorter than corresponding α1 and α2, and the loop connecting α5 and α6 is 7 residues 
shorter than the comparable loop in HTH1.   
 
46 
 
 
Figure 18. The SETMAR DNA-binding domain is a dimer. 
Each monomer has HTH1 and HTH2 motifs that bind the major-groove of DNA. A linker region 
containing two AT-hook motifs between them binds the minor-groove of DNA. HTH1 motifs from 
each of the monomers form a dimerization interface.  
 
Figure 19. Protein-protein interface of HTH1 motifs. 
Hydrophobic residues involved in the interface are shown as sticks. Two representative residues 
of the hydrophobic cluster, I341, F344, and F363, are labeled. 
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Overall, the structures of SETMAR DBDs bound to the TIR and variant DNA 
sequences are similar with an rmsd of 0.75 Å for superpositioning of 107 Cα atoms but 
differ specifically in the contacts made between HTH2 and the DNA (Figure 20). There 
are a total of 32 hydrogen bonding interactions between the protein and DNA in the TIR 
complex (Figure 21), 18 involving the phosphodiester backbone, and 20 in the 
variant-TIR complex structure, 13 of which are to the phosphodiester backbone (Figure 
22). The structures of the DNA also differ as expected due to differences in sequence 
(Figure 20) with the TIR DNA being primarily B-form, while that of the variant DNA 
includes several regions that deviate from this form, nucleobase pairs B17-B20/C9-G6 
and B9-B12/C17-C14 (with B and C referring to chain IDs). The second region differs in 
 
Figure 20. Superimposition of TIR and variant-TIR complex. 
HTH1 motifs superimpose quite well in the two complexes. In the HTH2 motif, the 
alpha helix 4 is shifted slightly away from the DNA in the variant-TIR complex (marine 
blue), compared to that of the TIR complex (orange). Alpha helices are shown as 
cylinders.  
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sequence from the TIR at position B10 with a T:A to C:G nucleobase-pair substitution 
and interacts with the first AT hook residue R392.  
In both structures, R371 in HTH1 motif makes a nucleobase-specific interaction 
within the major grove with atoms NE and NH2 forming two hydrogen bonds to O6 and 
N7 of G5, B chain (Figure 23). In HTH2, four residues (R417, H427, S428, and R432) make 
nucleobase-specific contacts with DNA in the major groove in the TIR complex while only 
two of these, R432 and S428, make nucleobase-specific contacts in the variant TIR 
complex (Figure 24). In the TIR complex, R417 forms two hydrogen bonds between its 
NH1 and NH2 atoms with N7 atom and O6 atom of C chain G5. H427 NE2 hydrogen 
bonds with O6 atom of C chain G6, S428 OG with atom N4 of B chain C18, R432 NH1 and 
NH2 with O6 atoms of B chain G17 and C chain G8, respectively, and R432 NH2 with N4 
atom of C chain C9. However, in the variant TIR complex, only S428 and R432 hydrogen 
bond to DNA (Figure 24).  
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Figure 21. Schematic diagram of hydrogen-bonding interactions between protein and 
DNA in the TIR complex. 
Red arrows are major groove base-specific contacts. Blue dotted arrows are minor groove 
contacts. Green broken arrows are interactions between protein and DNA backbone. 
 
Figure 22. Schematic diagram of hydrogen-bonding interactions between protein and 
DNA in the variant-TIR complex. 
Nucleotides different from the TIR DNA sequence are shown in blue. Red arrows are 
major groove base-specific contacts. Blue dotted arrows are minor groove contacts. 
Green broken arrows are interactions between protein and DNA backbone. 
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Figure 23. Close-up view of base-specific contacts made by Arg-371 in HTH1 motif. 
R371 makes two hydrogen bonds (broken lines) with the guanine-5 from chain B 
(labeled as bG5). Both TIR (left) and variant-TIR complex (right) show a similar 
interaction. Protein is renderer as a ribbon diagram. DNA is shown as line and surface 
rendering. Atoms oxygen and nitrogen are shown red and blue, respectively. Key 
residue side chain and bases are shown as ball-and-stick models. 
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SETMAR’s DBD includes two AT-hooks, one with a non-canonical sequence ERS 
(391-393) and the second a canonical GRP (394-396) (Aravind and Landsman 1998), in 
which the central Arg is bound to the minor groove of the DNA. Within this contact 
region in both structures, R392 is stabilized through an interaction with D389, which also 
interacts with R339. NH2 of R392 hydrogen bonds to N3 of either C chain A16 in the TIR 
or G16 in the variant TIR and NHE to O2 of T15 C chain (Figure 25). Note that in this case, 
the sequence variation between TIR and variant TIR does not affect the minor groove 
 
Figure 24. Close-up view of key differences in base-specific contacts in HTH2 motifs of TIR and 
variant-TIR complex. 
In the TIR complex (left column), key residues (R417, H427, S428, and R432) make 7 hydrogen 
bonds with DNA nucleobases. While in the variant-TIR complex (right column), two 
base-specific contacts are made by S428 and R432. Note that in the variant-TIR complex, the 
nucleobase in position 5 of the DNA chain C is T5 (labeled as cT5), instead of guanine in the 
TIR complex (labeled as cG5). Hydrogen bonds are shown in black broken lines. The TIR 
complex is on the left, variant-TIR complex on the right.  
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interactions. However, in the TIR complex, R395 is oriented with its guanidinium group 
such that NH1 points into the groove and hydrogen bonds with N3 of A12 (C chain) and 
with O2 of T15 (B chain) in a classic bifurcated type of interaction typically seen in 
narrow AT-rich minor grooves. (Figure 26) R395 is positioned by a hydrogen-bonding 
interaction of its NHE with OE2 of E398. Although the minor groove widths in both 
structures are similar in this region, the guanidinium group of R395 in the variant TIR 
complex is slightly rotated relative to the conformation in the TIR complex and forms a 
single hydrogen bond between NH1 and O2 of T15 (B chain) (Figure 26). In both 
structures, the AT-hooks also make several backbone interactions (Figure 21 and Figure 
22).  
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Figure 25. The interface between the N-terminal linker region and the DNA minor  
groove. 
Arg-339 and Asp-389 orientate Arg-392 to make contacts with DNA bases in the minor 
groove. Both TIR (top) and variant-TIR (bottom) complexes have similar contacts. Note 
that in the variant-TIR complex, the nucleobase in the position 16 of the DNA chain C is 
guanine (labeled as cG16), instead of adenine in the TIR complex (labeled as cA16). 
Hydrogen bonds are shown in black broken lines. Protein is rendered as a ribbon diagram. 
DNA is shown as line and surface rendering. Atoms oxygen and nitrogen are shown red 
and blue, respectively. Key residue side chains and bases are shown as ball-and-stick 
models. 
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Figure 26. Differences in DNA contacts in the interface between the C-terminal linker 
region and the DNA minor groove. 
The guanidinium groups of Arg-395 adopt different conformations in two complexes, 
resulting in different contacts between protein and DNA. In a classic bifurcated type of 
interaction mode, NH1 of Arg-395 hydrogen bonds with two bases: adenine 12 at chain C 
(labeled as cA12) and thymine 15 at chain B (labeled as bT15) (close-up view on top). In 
the variant-TIR complex (bottom, close-up view), the guanidinium group of R395 is slightly 
rotated relative to that in the TIR complex and forms a single hydrogen bond between NH1 
and O2 of thymine 15 at chain B (labeled as bT15). Note that in the TIR complex (top), OE2 
of Glu-398 makes hydrogen bond with NE atom of Arg-395. Hydrogen bonds are shown in 
black broken lines. Protein is rendered as a ribbon diagram. DNA is shown as a line and 
surface rendering. Atoms oxygen and nitrogen are shown red and blue, respectively. Key 
residue side chains and bases are shown as ball-and-stick models. 
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E. SETMAR binds TIR and variant TIR DNA with similar affinity  
In order to characterize the DNA-binding activity in the context of full-length 
SETMAR, we conducted fluorescence anisotropy (FA) assays using rhodamine-labeled 
DNA probes. A KD value of 53 ± 4 nM was measured for binding of SETMAR to an 
Hsmar1 TIR DNA probe as compared to 91 ± 7 nM for the variant DNA sequence used 
for crystallization (Figure 27). The reduction in binding affinity to the variant sequence is 
consistent with fewer nucleobase-specific hydrogen bonds formed between HTH2 and 
the DNA in this complex as compared to the TIR sequence. However, it is notable that 
the reduction in affinity is less than two-fold despite significant differences in the DNA 
sequence and its recognition pattern by HTH2. 
 
 
Figure 27. Fluorescence anisotropy (FA) assays characterize DNA-binding affinity of 
full-length SETMAR (FL SETMAR) and DNA. 
Rhodamine-labeled TIR or variant-TIR probes (10 nM) were titrated with increasing 
amount of SETMAR protein. Binding curves were fitted by fluorescence anisotropy (FA) 
against protein concentration. Kd value for TIR probe (Left) binding is 53 ± 4 nM. For 
variant-TIR probe (Right), Kd value is 91 ± 7 nM. Experiments were conducted with 
triplicate reading for three independent assays. 
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To assess the importance of specific nucleobases that interact with the HTH binding 
motifs, we examined the ability of mutant TIR or variant sequences to compete with 
labeled TIR or variant TIR DNA for binding to SETMAR by fluorescence anisotropy (See 
Table 6). First, we performed a competition assay using unlabeled DNA to compete off 
the fluorescently-labeled DNA probe in the protein-DNA complex. By replacing all 
nucleobase-specific interacting guanines (G) to adenines (A), the resulting G to A mutant 
TIR DNA was unable to compete off the probe, acting like the negative control Mos1 TIR 
DNA (Figure 28 A). Similarly, an oligonucleotide in which guanines that interact with 
SETMAR in the variant TIR complex were progressively replaced with adenines failed to 
compete effectively with the fluorescently-labeled variant DNA sequence (Figure 28 B). 
Name Sequence (5’—3’) 
Hsmar1 TIR TTAGGTTGGTGCAAAAGTAATTGCGGTT 
Mos1 TIR TCAGGTGTACAAGTATGAAATGTCGTTT 
Hsmar1 TIR without sequence-specific binding sites TTAGGTTAATATAAAAGTAATTGTGGTT 
Hsmar1 variant TIR TTAGCAGTGTGCAAAAGTGATTGCGGCT 
No_G variant TIR TTAGCAGTGTGCAAAAGTGATTGTGGCT 
No_CG variant TIR TTAGCAGGGTATAAAAGTGATTGCGGCT 
No_CGG variant TIR TTAGCAGTGTATAAAAGTGATTGTGGCT 
Table 6. DNA oligos for competition assay. 
The underlined bases are mutated from the Hsmar1 TIR sequence. 
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These results confirm that the nucleobase-specific interactions are important for 
DNA-binding activity of SETMAR. 
 
 
 
 
 
 
Figure 28. Competition assays of SETMAR with DNA probes. 
(A) Competition assay using various non-fluorescence labeled DNA sequences. 
Non-fluorescence labeled Hsmar1 TIR DNA (filled triangle) was titrated to compete off the 
bound TIR DNA probe from a complex, showing a curve with decreasing fluorescence 
polarization. Mos1 TIR (filled circle), a non-cognate DNA sequence for Hsmar1 
transposase, was unable to compete off the bound TIR DNA probe, serving as a negative 
control. As a consequence of substitutions of all key nucleotides involved in major groove 
interactions from guanine to adenine, a mutant Hsmar1 TIR DNA (empty circle) had no 
competition capability at all, behaving like the negative control. (B) Competition assay 
using non-fluorescence labeled mutant forms of variant-TIR DNA. Non-labeled variant-TIR 
DNA (empty triangle) was titrated to compete off the bound variant-TIR DNA probe from a 
complex, showing a curve with decreasing fluorescence polarization. Variant-TIR 
sequences bearing mutations in the key protein-recognition nucleotides were unable to 
compete off the probe. R371-contacting guanine was mutated to adenine (filled circle). 
S428 and R432 contacting CG dinucleotide was mutated to TA dinucleotide (empty circle). 
A mutant sequence carrying all above mentioned substitutions (filled triangle) had no 
competition activity at all. 
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To determine the contributions of specific amino acids within HTH1 and HTH2 to the 
DNA-binding activity of SETMAR, we substituted key residues with Ala and measured 
their binding affinity for the Hsmar1 TIR DNA probe. Residues selected for analysis 
include R371, S428, and R432 which make similar hydrogen bonding interactions in both 
TIR and variant sequences. KD values for binding of wild-type, R371A, S428A, and R432A 
to TIR DNA are 42, 521, 485, and 302 nM, respectively (Figure 29), consistent with an 
important role for these residues in this protein-DNA interaction. 
 
 
 
 
Figure 29. Mutations in key amino acid residues decrease DNA-binding affinity of SETMAR. 
DNA-binding assays were conducted as Figure 27. The binding affinity of the mutants 
decrease approximately 10-fold compared to that of wild-type SETMAR. Experiments were 
conducted with triplicate reading in three independent assays. 
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F. SETMAR binds DNA in cell-based assays 
SETMAR’s DBD comprising two HTH motifs is structurally very similar to the paired 
homeodomain family of transcription factors including PAX6, for which a DNA-bound 
crystal structure has been reported (Xu et al. 1999). Members of Tc1/mariner transposon 
superfamily share a common ancestor with PAX proteins (Breitling and Gerber 2000). 
Given that the DBD of SETMAR is derived from a Tc1/mariner superfamily transposon, 
we examined the possibility that SETMAR evolved to regulate gene expression. To test 
this hypothesis, we conducted luciferase reporter assays. Five tandem repeats of the 
Hsmar1 TIR sequence were inserted upstream of an SV40 promoter of the 
pGL3-Promoter Vector (Promega, Madison, WI), which we refer to as the 
pGL3-promoter-5xTIR. The luciferase reporter vector, pGL3-promoter-5xTIR, was 
cotransfected with the overexpression vector, pFLAG-CMV4-SETMAR(wt), into HEK293T 
cells, which have no detectible SETMAR expression (Williamson et al. 2008, De Haro et al. 
2010). Compared to a control experiment lacking the overexpression vector, SETMAR(wt) 
decreased the relative luciferase activity (Figure 30) by approximately 30%. However, 
SETMAR(R371A), a DNA-activity deficient mutant (Figure 29), was unable to repress the 
luciferase gene expression. Compared to wild-type protein, the R371A mutation doesn’t 
affect the expression of the SETMAR, based on western-blot result (Figure 30 inset). 
To confirm that the observed repression in the luciferase reporter assay results from 
binding of SETMAR to the TIR sequence within the plasmid, we conducted a ChIP assay 
in cells: in this case we measured SETMAR binding to TIR sequences embedded in 
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plasmid reporter DNA. Using the same vectors and cells as the luciferase reporter assay, 
FLAG-tagged SETMAR bound to DNA was immunoprecipitated using Anti-FLAG agarose 
beads, and TIR DNA was quantitated by qPCR resulting in a 3-fold higher signal than that 
of an IgG negative control group (Figure 31). Together with the luciferase results for the 
R371A mutant, this result is consistent with repression of luciferase activity by SETMAR 
resulting from TIR-specific binding activity.  
 
 
 
 
 
Figure 30. SETMAR represses transcription in a luciferase reporter assay. 
The pGL3-promoter-5xTIR (5xTIR) were co-transfected with pFLAG-CMV4-SETMAR(wt) or 
pFLAG-CMV4-SETMAR(R371A) into HEK293T cells. Error bars represent S.E.M. Samples 
significantly different between groups are indicated by asterisks (*: p<0.05, **: p<0.01). 
NS: non-significantly difference. Student t-test was used. Inset is the western-blot of 
FLAG-tag SETMAR(wt) and FLAG-tag SETMAR(R371A), showing that the residue 
substitution does not affect the protein expression level and the stability. 
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SETMAR has been demonstrated to promote repair and restart stalled replication 
forks. From the cisRED database (Robertson et al. 2006), we identified a potential 
SETMAR binding site within the promoter region (-113 to -93 bp region) of TOPBP1: 
5’-GGTTGGCGCGAAAGTCGGTTC -3’(bold letters are identical nucleobases in the Hsmar1 
TIR sequence, underlined letters indicate nucleobases involved in specific contacts with 
SETMAR or in the case of the final C, the complementary nucleobase). This sequence 
retains all of the nucleobases that are recognized in the major groove by SETMAR. 
TOPBP1, DNA topoisomerase II-binding protein 1, plays a role in the rescue of stalled 
replication forks and checkpoint control (Emmons et al. 1980, Emmons et al. 1983, Jurka 
et al. 2005). To determine whether SETMAR binds to the TOPBP1 promoter region, we 
performed a ChIP experiment with overexpression FLAG-tag SETMAR(wt) in HEK293T 
cells and found a 1.5-fold enrichment of bound SETMAR to the TOPBP1 promoter region 
 
Figure 31. SETMAR binds TIR sequence in cells. 
Using the same vectors and cells as Figure 30, FLAG fusion SETMAR is cross-linked to 
5xTIR vector DNA and then immunoprecipitated by anti-FLAG M2 affinity agarose. 
Purifed DNA was analyzed by quantitative Real-Time PCR, using primers flanking 
5xTIR sequence in the vector. The amount of immunoprecipitated DNA is 
represented as signal relative to IgG negative control. Data were presented as mean 
+/- SEM for three independent experiments (p<0.05). 
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as compared to the IgG negative control (Figure 32). This result is consistent with binding 
of SETMAR to the identified site within the TOPBP1 promoter.  
 
 
 
 
 
 
 
 
 
 
Figure 32. Binding of FLAG-tag SETMAR to the promoter region of TopBP1 gene in 
HEK293T cells is detected by ChIP assay.  
FLAG-tag SETMAR cross-linked on the chromatin in HEK293T cells was 
immunoprecipitated by Anti-FLAG M2 affinity agarose gel. The SETMAR-binding site in the 
promotor region of TopBP1 gene in the precipitated chromatin was detected by qPCR 
using specific primers for amplification of the -188 to -46 bp region. Mouse 
IgG-conjugated agarose was used as a negative control. Signals from anti-FLAG group were 
normalized to the IgG group. Data were presented as mean +/- SEM for three 
independent experiments (p<0.05). 
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DISCUSSION 
A. Structural basis of the sequence-specific binding activity of Hsmar1 
During the life cycle of a DNA transposon, one of the key steps for the encoded 
transposase is to specifically bind to its cognate TIRs that flank at each end of the 
transposon. This specificity ensures that each transposase can only recognize and bind 
its own TIR (Figure 1 and Figure 7). Also, binding to the TIR orients the catalytic domain 
for cleavage, which is normally within the outside end of the TIR (Figure 7). Dimerization 
of the DBD has been shown to pair the transposon ends to form a synaptic complex, or 
paired-end complex, such as Mos1 transposase (Richardson et al. 2009). The synaptic 
complex helps to coordinate cleavage at either end of the transposon. 
Since ancestral Hsmar1 entered the primate genome approximately 50 million years 
ago, the DBD has been under a strong purifying selection. The DBDs of Hsmar1 and 
SETMAR are highly conserved, with only two substituted amino acid residues: K330 and 
N426 in SETMAR, which are equivalent to E2 and D98 in Hsmar1, respectively 
(Robertson and Zumpano 1997, Cordaux et al. 2006, Miskey et al. 2007). In our TIR 
complex crystal structure, K330 is located on the N-terminus of the protein near the 
start of the first α helix. N426 is in the loop connecting α5 and α6. Neither of them 
interacts directly with the TIR DNA. Substitution of these two residues is unlikely to alter 
the structure significantly. Thus, the structure of the Hsmar1 TIR bound SETMAR DBD 
complex provides a basis for analyzing the sequence-specific binding activity of the 
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ancestral Hsmar1 transposase (hereafter Hsmar1 DBD and SETMAR DBD are used 
interchangeably).  
Overall, the HTH2 motif contributes more nucleobase-specific interactions than that 
of the HTH1 motif (Figure 21). In the HTHT1 motif, only one residue, R43 (R371 in 
SETMAR), makes nucleobase-specific interaction with TIR, while in HTH2 four residues 
R89, H99, S100, and R104 (R417, H427, S428, and R432 in SETMAR) interact with 
nucleobases (Figure 33). Both HTH motifs bind in the major groove of the TIR DNA 
(Figure 18).  
Our structural results now provide a detailed analysis of specific nucleobase 
interactions involved in formation of the SETMAR-DNA complex and are overall 
consistent with the reported 19-bp MBS identified by EMSA (Cordaux et al. 2006) in that 
all of the nucleobase specific contacts are contained within this site. Important 
 
Figure 33. Schematic diagram of sequence-specific binding of 
Hsmar1/SETMAR DNA-binding domain bound to Hsmar1 TIR. 
The simplified HTH1 and HTH2 motifs are presented on the top to show 
relative positions of the residues. Red arrows indicate the 
nucleobase-specific interactions. Black arrows indicate minor groove 
interactions from two AT-hook motifs. The amino acid numberings in 
the Hsmar1 transposase are shown as italics.  
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contributions to the overall binding affinity of SETMAR for either the TIR or variant TIR 
DNA sequences were assessed by mutation of the nucleobases in direct contact with the 
protein. The results of these binding assays were consistent with our structural analysis 
and confirm the assignment of minimal DNA sequence requirements for recognition by 
SETMAR. 
Crystal structures of the DBD or transposase complexed to cognate TIR DNA have 
been reported for two related transposases (Watkins et al. 2004, Richardson et al. 2009). 
Mos1, an active mariner transposon that was first identified in Drosophila mauritiana 
(Jacobson et al. 1986) and Tc3, a Tc1 transposon in the Caenorhabditis elegans genome 
(van Luenen et al. 1994). The architecture of the Mos1 DBD is similar to that of Hsmar1, 
with HTH motifs of similar size. However, the Mos1 DBD lacks AT-hook motifs found in 
Hsmar1 and has a major groove recognition pattern in which two residues of each HTH 
motif bind in the major groove (Figure 34). Interestingly, the Tc3 DBD includes two small 
HTH motifs similar to HTH2 in Hsmar1 and has two AT-hooks (R54 and R57) in the linker 
region that bind the minor groove of DNA. Unlike Hsmar1, however, Tc3 has more 
nucleobase-specific contact residues in HTH1 than that in HTH2. There are four in HTH1 
and two in HTH2 (Watkins et al. 2004) (Figure 34).  
The DNA sequences of TIRs are not conserved among Tc1/mariner family members 
(Figure 7); thus, each transposase recognizes the TIR of its own transposon specifically 
and acts only upon its own transposon ends. Differences in nucleobase-specific contacts 
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among Hsmar1, Mos1 and Tc3 reveal the structural basis of DNA recognition in the 
Tc1/mariner transposons. 
Similar to other members of the Tc1/mariner, Hsmar1 DBD forms a dimer. The 
dimeric interface is observed in the HTH1 motif, burying 1610 Å2 of the accessible 
surface (Figure 19). Hydrophobic residues from helices α1 and α2 constitute the 
interface. By analogy with the other known structures and studies on Mos1 and Tc3 
transposons (Watkins et al. 2004, Richardson et al. 2009), we infer from our structural 
analysis that the Hsmar1 transposon functions through a similar mechanism involving a 
dimeric DBD interaction with TIRs. It is of interest that SETMAR lacks the TIR-specific 
cleavage activity, examined by different transposition assay systems (Liu et al. 2007, 
 
Figure 34. Comparison of related DNA binding domain structures. 
The sequence-specific amino acid residues and AT-hook residues are represented as stick 
models in red color. PDB IDs are in parenthesis. Proteins are rendered as yellow ribbons. 
DNAs are shown as stick models with surface rendering. 
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Miskey et al. 2007) but still retains the dimeric structure that brings the two ends of the 
transposon together to form a synaptic complex as its ancestors did (Liu et al. 2007). 
 
B. SETMAR binds DNA with a conserved set of residues from Hsmar1 
In the process of molecular domestication of the Hsmar1 transposase gene 
downstream of the SET gene, a previously noncoding sequence between these two 
current exons was converted to encode a linker region. This linker region might serve as 
an N-terminal extension of the DBD by folding back to interact with the minor groove 
thereby providing another DNA-interacting element as seen in the Tc3-DNA complex 
(Watkins et al. 2004) (Figure 34). To explore this possibility in SETMAR, we made a DBD 
protein including 316-440, 14 amino acids longer than the 329-440 construct. In our 
structure of this DBD bound to DNA, the N-terminal residues 316-330 are disordered, 
and thus apparently are not involved in recognition of the DNA. 
However, a more critical insight comes from the structural analysis of the variant-TIR 
complex, obtained from co-crystallization of 316-440 with the variant-TIR DNA. Besides 
R371 in the HTH1 motif, specific interactions of conserved S428 and R432 involving C 
and G nucleobases, respectively, are indicated in the variant-TIR complex structure 
(Figure 24). This conserved set of sequence-specific residues is sufficient to retain high 
affinity binding to SETMAR in the variant-TIR complex (Figure 27), expanding 
considerably the number of potential binding sites in the human genome. 
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C. Biological significance of SETMAR DBD 
Transposons were commonly viewed as selfish or molecular parasitic entities to 
their host (Feschotte 2008, Sinzelle et al. 2009). However, accumulating studies have 
suggested that transposons have been a rich source of new DNA binding sites. For 
example, nearly 25% of known human promoters are derived from transposons (Jordan 
et al. 2003). In the human genome, it has been predicted that there are 1500-7000 
SETMAR binding sites (Robertson and Zumpano 1997, Cordaux et al. 2006). This pool of 
SETMAR binding sites hasn’t been systematically explored for their potential biological 
functions. 
Another beneficial effect of transposons is the creation of chimeric genes through 
molecular domestication (Quesneville et al. 2005, Casola et al. 2008, Sinzelle et al. 2009). 
The host recruits transposase-derived coding sequences, of which most are the DBD 
(Breitling and Gerber 2000, Babu et al. 2006, Feschotte 2008, Sinzelle et al. 2009). 
SETMAR is added to the growing list of transposase-derived DBD proteins. It is proposed 
that these DBD proteins are recruited as gene regulators (Feschotte 2008). PAX proteins, 
for instance, share a common ancestor as the members of Tc1/mariner superfamily 
(Breitling and Gerber 2000). They play key regulatory roles in early animal development, 
and missense mutations within the paired domain have been shown to cause disease 
(Hanson et al. 1994, Azuma et al. 1996). Interestingly, the DBD comprising two HTH 
motifs separated by a linker and referred to as a paired domain is found in a large 
number of protein families, such as Tc1/mariner superfamily and PAX family members. 
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The PAX6 DBD structure (Xu et al. 1999) includes yet another variation of the paired 
domain in which HTH2 is larger, similar to HTH1 in SETMAR, and HTH1 is smaller like 
HTH2 in SETMAR (Figure 34). There are no nucleobase-specific residues with HTH1 and 
only one in the HTH2 motif (Figure 34). 
Given that SETMAR binds tightly to TIR DNA in vitro (Figure 27), we examined the 
DNA-binding activity in cell-based assays. In the presence of the TIR binding site, 
SETMAR represses expression of luciferase in a reporter assay (Figure 30). SETMAR also 
binds the vector containing TIR sequence as assessed by a ChIP assay (Figure 31), 
consistent with both the DNA-binding and structural studies.  
The variant-TIR complex structure guided selection of a sequence within the 
promoter region of the TOPBP1 gene as a potential genomic binding site from cisRED 
(Robertson et al. 2006). TOPBP1 was of considerable interest as previous studies have 
shown that overexpression of SETMAR in HEK293T cells promotes restart of stalled 
replication forks (De Haro et al. 2010). Through ChIP analysis, SETMAR was shown to 
bind to the promoter region of TOPBP1 (Figure 4C). Thus, we conclude that SETMAR may 
play a key role in a number of gene regulatory networks through its function as a 
transcription factor. 
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